Lee Ainslie - Maverick Capital Ltd
Holding/activity history for Sanofi Aventis (SNY)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 24,581 | 0.01 | Buy | 0.01 | $48.18 | $1,184,313 | SEC |
| 2023 Q2 | 0 | 0.00 | Sell 100.00% | 0.01 | SEC | ||
| 2023 Q1 | 8,634 | 0.01 | Add 66.84% | <0.01 | $54.42 | $469,862 | SEC |
| 2022 Q4 | 5,175 | 0.01 | Buy | 0.01 | $48.43 | $250,625 | SEC |
| 2016 Q3 | 0 | 0.00 | Sell 100.00% | 0.02 | SEC | ||
| 2016 Q2 | 42,790 | 0.02 | Buy | 0.02 | $41.86 | $1,791,000 | SEC |
| 2016 Q1 | 0 | 0.00 | Sell 100.00% | 0.06 | SEC | ||
| 2015 Q4 | 91,300 | 0.06 | Reduce 10.18% | <0.01 | $42.65 | $3,894,000 | SEC |
| 2015 Q3 | 101,650 | 0.09 | $47.47 | $4,825,000 | SEC | ||
| 2015 Q2 | 101,650 | 0.08 | Buy | 0.08 | $49.53 | $5,035,000 | SEC |